rs371396859
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_004484.4(GPC3):c.176-40G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000408 in 1,126,908 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., 9 hem., cov: 22)
Exomes 𝑓: 0.000025 ( 0 hom. 6 hem. )
Consequence
GPC3
NM_004484.4 intron
NM_004484.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.199
Publications
0 publications found
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
- Simpson-Golabi-Behmel syndromeInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Simpson-Golabi-Behmel syndrome type 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-133953251-C-G is Benign according to our data. Variant chrX-133953251-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 259406.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00019 (21/110450) while in subpopulation AFR AF = 0.000593 (18/30379). AF 95% confidence interval is 0.000382. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000190 AC: 21AN: 110397Hom.: 0 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
21
AN:
110397
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000667 AC: 12AN: 179933 AF XY: 0.0000611 show subpopulations
GnomAD2 exomes
AF:
AC:
12
AN:
179933
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000246 AC: 25AN: 1016458Hom.: 0 Cov.: 24 AF XY: 0.0000203 AC XY: 6AN XY: 294932 show subpopulations
GnomAD4 exome
AF:
AC:
25
AN:
1016458
Hom.:
Cov.:
24
AF XY:
AC XY:
6
AN XY:
294932
show subpopulations
African (AFR)
AF:
AC:
16
AN:
24925
American (AMR)
AF:
AC:
3
AN:
35115
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
18898
East Asian (EAS)
AF:
AC:
0
AN:
29844
South Asian (SAS)
AF:
AC:
0
AN:
52290
European-Finnish (FIN)
AF:
AC:
0
AN:
38198
Middle Eastern (MID)
AF:
AC:
0
AN:
3893
European-Non Finnish (NFE)
AF:
AC:
0
AN:
769764
Other (OTH)
AF:
AC:
6
AN:
43531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000190 AC: 21AN: 110450Hom.: 0 Cov.: 22 AF XY: 0.000275 AC XY: 9AN XY: 32722 show subpopulations
GnomAD4 genome
AF:
AC:
21
AN:
110450
Hom.:
Cov.:
22
AF XY:
AC XY:
9
AN XY:
32722
show subpopulations
African (AFR)
AF:
AC:
18
AN:
30379
American (AMR)
AF:
AC:
1
AN:
10252
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2629
East Asian (EAS)
AF:
AC:
0
AN:
3511
South Asian (SAS)
AF:
AC:
0
AN:
2538
European-Finnish (FIN)
AF:
AC:
0
AN:
5874
Middle Eastern (MID)
AF:
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
AC:
0
AN:
52877
Other (OTH)
AF:
AC:
2
AN:
1494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.